Cleared Traditional

K063407 - BC-3200 AUTO HEMATOLOGY ANALYZER

K063407 is the FDA 510(k) clearance for BC-3200 AUTO HEMATOLOGY ANALYZER by Shenzhen Mindray Bio-Medical Electronics Co., Ltd.. It is a Class 2 Hematology device (product code GKZ) cleared through the Traditional 510(k) pathway after a 214-day FDA review.

K063407 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2007
Decision
214d
Days
Class 2
Risk

K063407 is an FDA 510(k) clearance for the BC-3200 AUTO HEMATOLOGY ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Great Neck, US). The FDA issued a Cleared decision on June 11, 2007 after a review of 214 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Mindray Bio-Medical Electronics Co., Ltd. devices

Submission Details

510(k) Number K063407 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 2006
Decision Date June 11, 2007
Days to Decision 214 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d slower than avg
Panel avg: 113d · This submission: 214d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K063407.
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
K081930 · Beckman Coulter, Inc. · Dec 2008
FLOWCARE TLG REAGENT
K081526 · Beckman Coulter, Inc. · Aug 2008
CYTOMICS FC 500 MPL FLOW CYTOMETER, MODEL # 626554
K071681 · Beckman Coulter, Inc. · Oct 2007
COULTER LH 780 HEMATOLOGY ANALYZER
K061616 · Beckman Coulter, Inc. · Oct 2006
COULTER LH 750 HEMATOLOGY ANALYZER, MODEL 6605632
K061574 · Beckman Coulter, Inc. · Jul 2006
CELL-DYN RUBY SYSTEM
K061667 · Abbott Laboratories · Jul 2006